to AI and LLM applications in SaMD. Drive the creation, approval, and continual enhancement of in-depth technical documentation, including advanced risk assessments, robust regulatory strategies, and sophisticated post-marketsurveillance plans tailored for AI-based medical products. Proactively monitor global regulatory developments, ensuring the company remains at the forefront of emerging regulatory trends and translating complex regulations More ❯
Oxford, Oxfordshire, United Kingdom Hybrid / WFH Options
Ultromics
eligibility evaluation. We are now expanding our reach, integrating into major healthcare systems and advancing partnerships with life sciences, pharma, and medtech companies to support drug trials and post-market surveillance. Our platform is poised to become the standard in AI-driven cardiovascular diagnostics, enabling better outcomes for patients and more efficient care delivery for providers. Why Join Us … initiatives. As a Clinical Research Scientist, you will work hand-in-hand with internal and external research and development teams to design high impact pre-clinical, pivotal, and post-market research projects, oversee completion of data collection, and lead the analysis and dissemination of scientific communications. You will play a key role throughout the product lifecycle, collaborating with AI … Scientists, Software Engineers, Product Teams, Marketing and Market Access, and Regulatory Experts to guide the development, evaluation, and integration of novel diagnostic and prognostic tools into the clinical workflow. Your Responsibilities Lead in the development of research and development protocols, including literature reviews, data selection mechanisms, data management plans, and statistical analysis plans. Contribute to product design and subsequent More ❯
Greater London, England, United Kingdom Hybrid / WFH Options
IXICO
Advanced analytics. Intelligent insights. IXICO plc (AIM: IXI), is a leading neuroimaging Contract Research Organization (CRO), delivering advanced Ai analytical insights in neuroscience to the global clinical trials market. Established in 2004, listed as a public company in 2013, IXICO More ❯